Skip Navigation


NDT Advance Access originally published online on July 26, 2005
Nephrology Dialysis Transplantation 2005 20(9):1789-1790; doi:10.1093/ndt/gfi016
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/9/1789    most recent
gfi016v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in NDT
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Flanigan, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flanigan, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Editorial Comment

Melagatran anticoagulation during haemodialysis—‘Primum non nocere’

Michael J. Flanigan

University of Iowa Hospitals, Iowa City, USA

Correspondence and offprint requests to: Michael J. Flanigan, Department of Internal Medicine, University of Iowa Hospitals, Iowa City, IA 52242-4060, USA. Email: michael-flanigan@uiowa.edu

The first 10% of the full text of this article appears below.

‘Primum non nocere’ or ‘First do no harm’ is attributed to Galen's translation of the Hippocratic Corpus (Epidemics, Bk. I, Sect. XI.), ‘Declare the past, diagnose the present, foretell the future; practice these acts. As to diseases, make a habit of two things—to help, or at least to do no harm’ [1,2].

In this issue . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in NDT:

Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia
Per-Ola Attman, Pia Ottosson, Ola Samuelsson, Ulf G. Eriksson, Maria Eriksson-Lepkowska, and Gunnar Fager
NDT 2005 20: 1889-1897. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
P.-O. Attman
Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1738 - 1738.
[Full Text] [PDF]